S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:OTIC

Otonomy News Headlines

$2.00
-0.07 (-3.38%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.97
$2.07
50-Day Range
$1.69
$2.25
52-Week Range
$1.14
$6.98
Volume
356,573 shs
Average Volume
574,442 shs
Market Capitalization
$113.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.79

Media Mentions By Week



Otonomy Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OTIC
News Sentiment

0.00

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OTIC Articles
This Week

0

2

OTIC Articles
Average Week

Get Otonomy News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter.

Otonomy (NASDAQ:OTIC) News Headlines Today

SourceHeadline
MarketBeat logo-$0.17 EPS Expected for Otonomy, Inc. (NASDAQ:OTIC) This Quarter
americanbankingnews.com - November 24 at 5:16 AM
finance.yahoo.com logoAGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer - Yahoo Finance
finance.yahoo.com - November 16 at 12:51 PM
finance.yahoo.com logoOtonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
finance.yahoo.com - November 16 at 7:50 AM
MarketBeat logoOtonomy, Inc. Expected to Post Q4 2021 Earnings of ($0.15) Per Share (NASDAQ:OTIC)
americanbankingnews.com - November 15 at 2:46 AM
MarketBeat logoOtonomy (NASDAQ:OTIC) Announces Quarterly Earnings Results
americanbankingnews.com - November 13 at 2:14 PM
MarketBeat logoOtonomy (NASDAQ:OTIC) Stock Rating Reaffirmed by Cantor Fitzgerald
americanbankingnews.com - November 13 at 6:56 AM
finance.yahoo.com logoOtonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - November 10 at 11:26 PM
finance.yahoo.com logoAGTC to Participate in the Stifel 2021 Virtual Healthcare Conference - Yahoo Finance
finance.yahoo.com - November 10 at 1:25 PM
streetinsider.com logoAGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021 - StreetInsider.com
streetinsider.com - November 9 at 9:50 AM
finance.yahoo.com logoOtonomy to Report Third Quarter 2021 Financial Results and Provide Corporate Update - Yahoo Finance
finance.yahoo.com - November 3 at 8:14 AM
finance.yahoo.com logoOtonomy to Report Third Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - November 3 at 8:14 AM
nasdaq.com logoOtonomy (OTIC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Nasdaq
nasdaq.com - October 27 at 6:36 PM
finance.yahoo.com logoOtonomy (OTIC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 27 at 6:36 PM
globenewswire.com logoOtonomy Announces Multiple Presentations at Neuroscience 2021 Meeting - GlobeNewswire
globenewswire.com - October 27 at 1:35 PM
finance.yahoo.com logoOtonomy Announces Multiple Presentations at Neuroscience 2021 Meeting
finance.yahoo.com - October 27 at 8:35 AM
streetinsider.com logoAGTC to Present at Upcoming Cell & Gene Meeting on the Mesa - StreetInsider.com
streetinsider.com - October 13 at 9:56 AM
finance.yahoo.com logoOtonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313 - Yahoo Finance
finance.yahoo.com - October 12 at 6:12 PM
finance.yahoo.com logoAGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa - Yahoo Finance
finance.yahoo.com - October 12 at 8:11 AM
globenewswire.com logoOtonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313 - GlobeNewswire
globenewswire.com - October 12 at 8:11 AM
finance.yahoo.com logoOtonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
finance.yahoo.com - October 12 at 8:11 AM
finance.yahoo.com logoAGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - September 28 at 1:09 PM
globenewswire.com logoOtonomy Announces Presentation of OTO-413 Clinical Results - GlobeNewswire
globenewswire.com - September 27 at 10:18 AM
finance.yahoo.com logoWhat Is The Ownership Structure Like For Otonomy, Inc. (NASDAQ:OTIC)?
finance.yahoo.com - September 22 at 1:55 PM
finance.yahoo.com logoAGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021 - Yahoo Finance
finance.yahoo.com - September 16 at 5:53 PM
finance.yahoo.com logoAGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study - Yahoo Finance
finance.yahoo.com - September 9 at 2:31 PM
businesswire.com logoGlobal Tinnitus Drug Pipeline Landscape Report 2021 - ResearchAndMarkets.com - Business Wire
businesswire.com - September 9 at 2:31 PM
finance.yahoo.com logoAGTC is Excited to Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber as their new Chief Financial Officer - Yahoo Finance
finance.yahoo.com - September 8 at 3:45 PM
benzinga.com logoReturn on Capital Employed Overview: Otonomy - Benzinga
benzinga.com - August 20 at 2:44 PM
globenewswire.com logoOtonomy Appoints Jill Broadfoot to Board of Directors - GlobeNewswire
globenewswire.com - August 19 at 9:21 AM
finance.yahoo.com logoOtonomy Appoints Jill Broadfoot to Board of Directors
finance.yahoo.com - August 19 at 9:21 AM
finance.yahoo.com logoAGTC to Participate in Envision Virtual Conference East 2021 Panel Discussion - Yahoo Finance
finance.yahoo.com - August 16 at 2:59 PM
seekingalpha.com logoOtonomy, Inc. (OTIC) CEO David Weber on Q2 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 5 at 7:38 AM
globenewswire.com logoOtonomy Reports Second Quarter 2021 Financial Results and - GlobeNewswire
globenewswire.com - August 4 at 8:17 PM
finance.yahoo.com logoOtonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - August 4 at 8:17 PM
finance.yahoo.com logoAGTC to Participate at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - August 2 at 7:26 PM
finance.yahoo.com logoWill Otonomy (OTIC) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance
finance.yahoo.com - July 28 at 9:24 AM
finance.yahoo.com logoOtonomy to Report Second Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - July 28 at 9:24 AM
nasdaq.com logoOtonomy, Inc. Common Stock (OTIC)
nasdaq.com - July 27 at 11:55 PM
finance.yahoo.com logoWill Otonomy (OTIC) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 27 at 6:55 PM
markets.businessinsider.com logoThe Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay - Markets Insider
markets.businessinsider.com - July 21 at 12:19 PM
seekingalpha.com logoApplied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk - Seeking Alpha
seekingalpha.com - July 15 at 9:21 PM
barrons.com logoOtonomy Inc.
barrons.com - June 26 at 8:42 AM
businesswire.com logoH1 2021 Tinnitus Global Clinical Trials Review - Featuring Otonomy, Abbott Laboratories & Atoll Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - June 23 at 7:17 PM
finance.yahoo.com logoH1 2021 Tinnitus Global Clinical Trials Review - Featuring Otonomy, Abbott Laboratories & Atoll Among Others - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 22 at 10:09 PM
benzinga.com logoLooking Into Otonomy's Return On Capital Employed - Benzinga
benzinga.com - June 18 at 12:49 PM
benzinga.com logoLooking Into Otonomy's Return On Capital Employed - Benzinga - Benzinga
benzinga.com - June 17 at 8:09 PM
streetinsider.com logoOtonomy (OTIC) Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss - StreetInsider.com
streetinsider.com - June 16 at 8:19 AM
finance.yahoo.com logoIncreases to CEO Compensation Might Be Put On Hold For Now at Otonomy, Inc. (NASDAQ:OTIC)
finance.yahoo.com - June 16 at 8:19 AM
globenewswire.com logoOtonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss - GlobeNewswire
globenewswire.com - June 15 at 12:00 PM
finance.yahoo.com logoOtonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss
finance.yahoo.com - June 15 at 12:00 PM
Get Otonomy News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.